Latest News and Press Releases

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...

JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of...

Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...

Experts and institutions we trusted have been corrupted, and are using their power to silence dissenters. The pandemic response is one of many examples.

ROCKAWAY, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...

WALTHAM, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today...

Washington, D.C., Jan. 30, 2024 (GLOBE NEWSWIRE) -- In May 2023, U.S. Surgeon General Vivek Murthy, M.D., M.B.A., called loneliness a public health epidemic. The latest Healthy Minds Monthly Poll...

InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization (EUA) but do not survive. InflaRx is determined to support broader access to GOHIBIC for...

AAPS Educational Foundation challenges censorship imposed by revoking physicians' board certification, and the Biden regime's Disinformation board.

The extreme measures responding to COVID, which was treated as a national security, not a public health issue, caused great harm. Doctors must speak out.